More and more patients worldwide report positive experiences with MSC cell therapies. Clinical results confirm the therapeutic potential of mesenchymal stem cells across a wide spectrum of medical conditions, from orthopedic issues to autoimmune diseases.
One of the most common applications of MSC therapy is knee osteoarthritis treatment. Patients frequently report pain reduction within the first weeks after application, with full therapeutic effect typically developing over 3-6 months.
In chronic wounds such as diabetic ulcers, MSC therapies show exceptional results. Wounds that had not healed for months or even years despite conventional treatment often begin healing within weeks after MSC cell application.
It is important to emphasize that cell therapy results are individual and depend on numerous factors, including the type and severity of the disease, patient age, and overall health status. GaiaCell approaches each patient individually and sets realistic expectations.
GaiaCell's clinical observations and studies consistently show that MSC therapy is safe and well-tolerated. Side effects are rare and usually mild, which is consistent with global clinical data on MSC cell therapy safety.